Pricing and access
Transparent quotas, never credits.
Transparent pricing, documented quotas, and a published price, no opaque per-use charges. Usage dashboards show where you stand against your quota in real time.
Six commercial tiers
From free academic to public-health authority.
Regional pricing reaches Tier 2 markets by design, the same product, priced for access. Published prices are set per market; this page describes the approach.
Free academic
Individual academic researchers and students.
Transparent quota against documented limits. No credits, no consumption metering.
- Lumen literature retrieval and methodology consensus
- Core capability access within documented quotas
- Citation export in all supported formats
Free for qualifying academic use.
Paid academic
Academic labs and university bioinformatics cores needing higher throughput.
Higher documented quotas, billed against a published price, not per-action rates.
- Expanded literature and workflow-execution quotas
- Reproducibility certificates and provenance
- Lab-in-the-loop feedback through Labtrack
Published academic pricing with regional accessibility for Tier 2 markets.
SMB biotech
Small and mid-size biotechnology R&D teams.
Team quotas with a usage dashboard reporting against documented limits in real time.
- Full closed-loop capability access
- Omnix predictive modelling, every model explainable
- Pre-flight cost transparency for heavy-compute runs
Published team pricing. Pre-flight estimates before any heavy-compute operation.
Pharma R&D
Pharmaceutical research and development organisations.
Organisation-scale quotas with workspace governance and provenance throughout.
- Organisation workspaces and role governance
- Full provenance and reproducibility certificates
- Multi-region data residency
Published organisation pricing. Quota-against-usage, never credit balances.
Hospital research
Hospital research arms, genomics laboratories, and pathology research teams.
Research-tier access with the decision-support boundary surfaced throughout.
- Every output marked research-only
- Decision-support and evidence-ranked briefs through Oris
- Built for research data, clinical systems stay separate
Published research-tier pricing. The platform suggests; the clinician decides.
Public health authority
National and regional public-health authorities and policy makers.
Authority-tier access to surveillance liberation and policy briefs.
- Surveillance data, unified
- Outbreak modelling and AMR surveillance with data-freshness indicators
- Evidence-ranked policy briefs, the decision authority remains with the user
Published authority pricing with multi-region regulatory equality.
Billing trust
No surprises in the bill.
No credits, tokens, or consumed units anywhere in the model. You are billed against documented quotas, not a depleting balance.
Usage dashboards report per-user and per-workspace consumption against quota in real time.
Heavy-compute operations surface a pre-flight cost and timing estimate, requiring explicit acknowledgement before they run.
Multi-region regulatory equality: no region is privileged in pricing posture.